RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - Condensed Consolidated Statements of Shareholders' Equity (Details) - USD ($) $ in Thousands |
2 Months Ended | 3 Months Ended | 6 Months Ended | 9 Months Ended | 10 Months Ended | 12 Months Ended | ||||
---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2021 |
Sep. 30, 2022 |
Jun. 30, 2022 |
Mar. 31, 2022 |
Jun. 30, 2022 |
Sep. 30, 2022 |
Nov. 08, 2021 |
Dec. 31, 2022 |
Dec. 31, 2020 |
|
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||
Beginning balance (in shares) | 162,637,029 | 157,237,435 | 157,237,435 | 157,237,435 | 157,237,435 | |||||
Beginning balance | $ 252,443 | $ 1,476,881 | $ 1,128,963 | $ 1,137,982 | $ 1,081,618 | $ 1,081,618 | $ 1,081,618 | $ 291,422 | $ 1,081,618 | $ 262,386 |
Beginning balance (in shares) | 597,513 | 0 | 0 | 0 | 0 | |||||
Share-based compensation | 290,846 | $ (845) | 3,433 | $ 4,963 | 156 | $ 14,649 | ||||
Ordinary shares repurchased (in shares) | 6,436,736 | |||||||||
Ordinary shares repurchased | (2,564) | (5,008) | $ (49,341) | |||||||
Net income (loss) | $ (682,149) | (682,149) | 106,227 | 8,927 | 36,963 | $ 45,890 | $ 152,117 | 20,629 | 91,758 | 24,249 |
Other comprehensive loss | $ (7,135) | $ (18,181) | $ (16,371) | 236 | $ (18,336) | 4,787 | ||||
Ending balance (in shares) | 157,237,435 | 157,237,435 | 162,316,326 | 162,637,029 | 162,637,029 | 162,316,326 | 156,797,806 | |||
Ending balance | $ 1,081,618 | $ 1,081,618 | $ 1,213,600 | $ 1,128,963 | $ 1,137,982 | $ 1,128,963 | $ 1,213,600 | $ 252,443 | $ 1,138,900 | $ 291,422 |
Ending balance (in shares) | 0 | 0 | 918,216 | 597,513 | 597,513 | 918,216 | 6,436,736 | |||
Common Stock | ||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||
Beginning balance (in shares) | 53,045,510 | 156,937,410 | 163,234,542,000 | 163,234,542,000 | 157,237,435 | 157,237,435 | 157,237,435 | 53,045,510 | 157,237,435 | 53,045,510 |
Beginning balance | $ 53,046 | $ 156,937 | $ 163,235 | $ 163,235 | $ 157,237 | $ 157,237 | $ 157,237 | $ 53,046 | $ 157,237 | $ 53,046 |
Ending balance (in shares) | 157,237,435 | 157,237,435 | 163,234,542,000 | 163,234,542,000 | 163,234,542,000 | 163,234,542,000 | 163,234,542,000 | 53,045,510 | 163,234,542 | 53,045,510 |
Ending balance | $ 157,237 | $ 157,237 | $ 163,235 | $ 163,235 | $ 163,235 | $ 163,235 | $ 163,235 | $ 53,046 | $ 163,235 | $ 53,046 |
Treasury Shares | ||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||
Beginning balance | $ 0 | $ 0 | $ (5,008) | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 |
Beginning balance (in shares) | 0 | 0 | 597,513,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Ordinary shares repurchased (in shares) | 320,703,000 | 597,513,000 | 6,436,736 | |||||||
Ordinary shares repurchased | $ (2,564) | $ (5,008) | $ (49,341) | |||||||
Ending balance | $ 0 | $ 0 | $ (7,572) | $ (5,008) | $ 0 | $ (5,008) | $ (7,572) | $ 0 | $ (49,341) | $ 0 |
Ending balance (in shares) | 0 | 0 | 918,216,000 | 597,513,000 | 0 | 597,513,000 | 918,216,000 | 0 | 6,436,736 | 0 |
Additional Paid-in Capital | ||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||
Beginning balance | $ 229,500 | $ 1,376,312 | $ 1,686,743 | $ 1,683,310 | $ 1,670,033 | $ 1,670,033 | $ 1,670,033 | $ 289,344 | $ 1,670,033 | $ 289,344 |
Share-based compensation | 290,846 | (845) | 3,433 | 4,963 | 156 | 14,649 | ||||
Net income (loss) | 0 | |||||||||
Ending balance | 1,670,033 | 1,670,033 | 1,685,898 | 1,686,743 | 1,683,310 | 1,686,743 | 1,685,898 | 229,500 | 1,698,781 | 289,344 |
Accumulated Other Comprehensive Loss | ||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||
Beginning balance | (2,938) | 0 | (23,380) | (7,009) | (7,135) | (7,135) | (7,135) | (3,174) | (7,135) | (7,961) |
Other comprehensive loss | (7,135) | (18,181) | (16,371) | 236 | (18,336) | 4,787 | ||||
Ending balance | (7,135) | (7,135) | (41,561) | (23,380) | (7,009) | (23,380) | (41,561) | (2,938) | (25,471) | (3,174) |
Accumulated Deficit | ||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||
Beginning balance | (27,165) | (56,368) | (692,627) | (701,554) | (738,517) | (738,517) | (738,517) | (47,794) | (738,517) | (72,043) |
Share-based compensation | 0 | |||||||||
Net income (loss) | (682,149) | (682,149) | 106,227 | 8,927 | 36,963 | 20,629 | 91,758 | 24,249 | ||
Ending balance | (738,517) | (738,517) | (586,400) | (692,627) | (701,554) | (692,627) | (586,400) | $ (27,165) | (648,304) | $ (47,794) |
As Reported | ||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||
Beginning balance | 1,133,868 | 1,141,283 | 1,083,310 | 1,083,310 | 1,083,310 | 1,083,310 | ||||
Share-based compensation | 6,832 | 6,741 | 5,724 | |||||||
Ordinary shares repurchased | (2,564) | (5,008) | ||||||||
Net income (loss) | (680,457) | 78,711 | 7,223 | 37,811 | 45,034 | 123,745 | ||||
Other comprehensive loss | (18,181) | (16,371) | ||||||||
Ending balance | 1,083,310 | 1,083,310 | $ 1,198,666 | $ 1,133,868 | $ 1,141,283 | $ 1,133,868 | $ 1,198,666 | |||
As Reported | Common Stock | ||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||
Beginning balance (in shares) | 163,234,542,000 | 163,234,542,000 | ||||||||
Beginning balance | $ 163,235 | $ 163,235 | ||||||||
Ending balance (in shares) | 163,234,542,000 | 163,234,542,000 | 163,234,542,000 | 163,234,542,000 | 163,234,542,000 | |||||
Ending balance | $ 163,235 | $ 163,235 | $ 163,235 | $ 163,235 | $ 163,235 | |||||
As Reported | Treasury Shares | ||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||
Beginning balance | $ (5,008) | $ 0 | ||||||||
Beginning balance (in shares) | 597,513,000 | 0 | ||||||||
Ordinary shares repurchased (in shares) | 320,703,000 | 597,513,000 | ||||||||
Ordinary shares repurchased | $ (2,564) | $ (5,008) | ||||||||
Ending balance | $ (7,572) | $ (5,008) | $ 0 | $ (5,008) | $ (7,572) | |||||
Ending balance (in shares) | 918,216,000 | 597,513,000 | 0 | 597,513,000 | 918,216,000 | |||||
As Reported | Additional Paid-in Capital | ||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||
Beginning balance | $ 1,690,812 | $ 1,684,071 | $ 1,670,033 | $ 1,670,033 | $ 1,670,033 | 1,670,033 | ||||
Share-based compensation | 6,832 | 6,741 | 5,724 | |||||||
Net income (loss) | 0 | |||||||||
Ending balance | 1,670,033 | 1,670,033 | 1,697,644 | 1,690,812 | 1,684,071 | 1,690,812 | 1,697,644 | |||
As Reported | Accumulated Other Comprehensive Loss | ||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||
Beginning balance | (23,380) | (7,009) | ||||||||
Other comprehensive loss | (18,181) | (16,371) | ||||||||
Ending balance | (41,561) | (23,380) | (7,009) | (23,380) | (41,561) | |||||
As Reported | Accumulated Deficit | ||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||
Beginning balance | (691,791) | (699,014) | (736,825) | (736,825) | (736,825) | (736,825) | ||||
Share-based compensation | 0 | |||||||||
Net income (loss) | (680,457) | 78,711 | 7,223 | 37,811 | ||||||
Ending balance | (736,825) | (736,825) | (613,080) | (691,791) | (699,014) | (691,791) | (613,080) | |||
Adjustment | ||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||
Beginning balance | (4,905) | (3,301) | (1,692) | (1,692) | (1,692) | (1,692) | ||||
Share-based compensation | (7,677) | (3,308) | (761) | |||||||
Net income (loss) | (1,692) | 27,516 | 1,704 | (848) | 856 | 28,372 | ||||
Ending balance | (1,692) | (1,692) | $ 14,934 | $ (4,905) | $ (3,301) | $ (4,905) | $ 14,934 | |||
Adjustment | Common Stock | ||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||
Beginning balance (in shares) | 0 | 0 | ||||||||
Beginning balance | $ 0 | $ 0 | ||||||||
Ending balance (in shares) | 0 | 0 | 0 | 0 | 0 | |||||
Ending balance | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | |||||
Adjustment | Treasury Shares | ||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||
Beginning balance | $ 0 | $ 0 | ||||||||
Beginning balance (in shares) | 0 | 0 | ||||||||
Ending balance | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | |||||
Ending balance (in shares) | 0 | 0 | 0 | 0 | 0 | |||||
Adjustment | Additional Paid-in Capital | ||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||
Beginning balance | $ (4,069) | $ (761) | $ 0 | $ 0 | $ 0 | 0 | ||||
Share-based compensation | (7,677) | (3,308) | (761) | |||||||
Net income (loss) | 0 | |||||||||
Ending balance | 0 | 0 | (11,746) | (4,069) | (761) | (4,069) | (11,746) | |||
Adjustment | Accumulated Other Comprehensive Loss | ||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||
Beginning balance | 0 | 0 | ||||||||
Ending balance | 0 | 0 | 0 | 0 | 0 | |||||
Adjustment | Accumulated Deficit | ||||||||||
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ||||||||||
Beginning balance | (836) | (2,540) | (1,692) | (1,692) | (1,692) | $ (1,692) | ||||
Share-based compensation | 0 | |||||||||
Net income (loss) | (1,692) | 27,516 | 1,704 | (848) | ||||||
Ending balance | $ (1,692) | $ (1,692) | $ 26,680 | $ (836) | $ (2,540) | $ (836) | $ 26,680 |